Investor information

 

  • TSX: ERG.V0.87+0.01 - +1.16%
  • The price of the Toronto stock exchange always takes precedence over this one

Ergoresearch: Continuous Innovation!

The healthcare market has recently been faced with a number of challenges and Ergoresearch is a solution to our society’s issues.

Ergoresearch works in the field of healthcare, a market that’s in full growth due to aging populations. The company has been developing innovative orthopedic products and solutions impacting pain management that are economically efficient and often reimbursed by third-party payers. Ergoresearch products are non-invasive and non-toxic biomechanical devices offering patient benefits that are well supported by a substantial body of clinical proof, and convincing scientific data.

Ergoresearch has developed the most important orthotics network in Québec, with over one hundred clinics and satellite centers flying under the banners of Clinique du pied Équilibre, Orthoconcept and Laboratoire Langelier. Québec’s leading manufacturer of “intelligent” foot orthotics and specialty orthotics, it is a trend-setter in creating durable medical equipment and software for the orthopedics market. Through its subsidiary Victhom Human Bionics, it also owns patents in the field of bionics including intellectual property for the Power Knee, the world’s only motor-powered prosthesis for above-knee amputees.

Ergoresearch has created and commercialized WebFit™, the first robotized custom-fit orthotics manufacturing software program, launched the first knee osteoarthritis Living Lab in Canada, and a new generation of world-patented orthotic device, the OdrA, that revolutionizes the treatment of pain associated with knee osteoarthritis. Ergoresearch Ltd is listed on the TSX Venture Exchange (TSXV) under the symbol ERG.

 

Our branchs:

ortho pied  langelier

ergoVicthom_web

Réalisation Web Sept24